Custom Search


Portfolio of Biotech Stocks: Arthritis

Here is a sample of 4 biotech stocks that provide arthritis treatments.

Biotech Stocks: Arthritis
Stock
Price Quote & Dividend
1-Yr Price Chart
Amgen
Antares Pharma
Horizon Pharma plc
Incyte Corporation
Price and dividend data from Quandl.


To inspect the performance of the Biotech Stocks: Arthritis portfolio, see the returns table and chart below. Portfolio values are computed using monthly closes for from Quandl.

The 3 included in the portfolio computations are: AMGN, ATRS and INCY. The current value of the portfolio assumes that $3,333.33 was invested (total of $10,000) in each at its closing weekly price for the current date in 2008. HZNP was excluded from the portfolio computations because of insufficient price data.


Biotech Stocks: Arthritis - Return Results
Portfolio:
Biotech Stocks: Arthritis
Start date:
May-21-2008
Start value:
$10,000
End date:
May-21-2018
End value:
$48,756
Number prices
121
Minimum value occurred on Apr-30-2009
$6,127
Maximum value occurred on Aug-31-2017
$74,357
Total gain or loss (Start date to End date)
387.56%
Annualized gain or loss (Start date to End date)
17.17%
Total dollar value on End date of a $10,000 purchase made on Start date
$48,756
Average percent return for all possible buy/sell combinations
163.01%
Number returns
7,260
Number profitable returns (Winners)
6,561
Percent profitable returns
90.37%
Number unprofitable returns (Losers)
699
Percent unprofitable returns
9.63%
Winners to losers ratio
9.39
Stock Return Calculator





Related Articles

Portfolio of Big Pharmaceuticals Stocks: Arthritis
Portfolio of Biotech Stocks
Portfolio of Biotech Stocks: Cancer
Portfolio of Biotech Stocks: Diabetes
Portfolio of Biotech Stocks: Hepatitis C
Portfolio of Dividend-Paying Pharmaceutical Stocks
Portfolio of Generic Drug Stocks